Quotient Bio Analytical Sciences was acquired by LGC on 24th December 2012. Please see the following press release for further details: LGC acquires leading bioanalytical sciences business from Quotient Bioresearch
High quality global laboratory services for multi-centre clinical trials to help you get the most from your precious samples.
Your trial is unique and we understand the impact the laboratory service you choose can have on every aspect of your work from monitors and investigators to patient care and data quality. Whether from a single-centre Phase I study or a global Phase IV trial, every sample is precious and the increasing desire to obtain more safety and efficacy information earlier in development is driving the design of complex protocols with multiple endpoints from each of these precious samples.
QC Global™ is the name of our integrated services for multi-centre clinical trials provided in partnership with Clinical Reference Laboratory, Inc. (CRL). Our QC Global service brings together Quotient’s expertise and broad capabilities in bioanalysis of drugs and biomarkers and CRL's 20 years of experience in global trial management combined with an established network of standardised laboratories and alliance laboratories in all major clinical trial regions of the world.
CRL’s laboratory, headquartered in Kansas, USA, is one of the world's largest privately owned clinical testing laboratories with a wholly owned European facility located within Quotient Bioresearch at Fordham, near Cambridge, UK. These two facilities, combined with regional laboratories in Latin America, South Africa, India, China, Japan, Singapore and Australia, operate standardised instrument platforms and all data is centrally managed to provide an efficient, cost effective and flexible service available via OASIS, a secure web portal.
Our services are tailored to meet the needs of every clinical trial:
Find out more about Quotient and CRL's collaboration
PK/PD - Pharmacokinetic/pharmacodynamic